Cl- currents activated by extracellular nucleotides in human bronchial cells

J Membr Biol. 1997 Apr 1;156(3):297-305. doi: 10.1007/s002329900209.

Abstract

The perforated-patch technique was used to study the response of human bronchial cells to extracellular nucleotides. ATP or UTP (100 microm) elicited a complex response consisting of a large transient membrane current increase followed by a relatively small sustained level. These two phases were characterized by different current kinetics. Throughout the transient phase (2-3 min) the membrane current (Ip) displayed slow activation and deactivation kinetics at depolarizing and hyperpolarizing potentials respectively. At steady-state (Is) the relaxation at hyperpolarizing potential disappeared whereas at positive membrane potentials the current became slightly deactivating. The Is amplitude was dependent on the extracellular Ca2+ concentration, being completely inhibited in Ca2+-free medium. Cell pre-incubation with the membrane-permeable chelating agent BAPTA/AM prevented completely the response to nucleotides, thus suggesting that both Ip and Is were dependent on intracellular Ca2+. The presence of a hypertonic medium during nucleotide stimulation abolished Is leaving Ip unchanged. On the contrary, niflumic acid, a blocker of Ca2+-activated Cl- channels, prevented completely Ip without reducing significantly Is. 1, 9-dideoxyforskolin fully inhibited Is but also reduced Ip. Replacement of extracellular Cl- with aspartate demonstrated that the currents activated by nucleotides were Cl- selective. Ip resulted five times more Cl- selective than Is with respect to aspartate. Taken together, our results indicate that ATP and UTP activate two types of Cl- currents through a Ca2+-dependent mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology*
  • Bronchi / cytology
  • Bronchi / drug effects*
  • Calcium / physiology*
  • Cells, Cultured
  • Chelating Agents / pharmacology
  • Chlorides / metabolism*
  • Colforsin / analogs & derivatives
  • Colforsin / pharmacology
  • Cystic Fibrosis / metabolism
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Epithelial Cells
  • Epithelium / drug effects
  • Extracellular Space / metabolism
  • Humans
  • Intracellular Fluid / metabolism
  • Ion Transport / drug effects
  • Membrane Potentials / drug effects
  • Niflumic Acid / pharmacology
  • Patch-Clamp Techniques
  • Uridine Triphosphate / pharmacology*

Substances

  • Chelating Agents
  • Chlorides
  • 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester
  • Colforsin
  • Niflumic Acid
  • Egtazic Acid
  • Adenosine Triphosphate
  • 1,9-dideoxyforskolin
  • Calcium
  • Uridine Triphosphate

Grants and funding